These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 35405968)

  • 1. Role of Zinc in Diabetic Kidney Disease.
    Gembillo G; Visconti L; Giuffrida AE; Labbozzetta V; Peritore L; Lipari A; Calabrese V; Piccoli GB; Torreggiani M; Siligato R; Santoro D
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetic Kidney Disease 3rd stage - laboratory markers of mineral bone disorder].
    Klimentová A; Ságová I; Prídavková D; Kantárová D; Makovický P; Sadloňová J; Mokáň M
    Vnitr Lek; 2016; 62(6):442-8. PubMed ID: 27485841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
    Ruilope LM; Segura J
    Clin Ther; 2003 Dec; 25(12):3044-64. PubMed ID: 14749145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic kidney disease in Australia: current burden and future projections.
    White S; Chadban S
    Nephrology (Carlton); 2014 Aug; 19(8):450-8. PubMed ID: 24888506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia.
    Gembillo G; Ingrasciotta Y; Crisafulli S; Luxi N; Siligato R; Santoro D; Trifirò G
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic Nephropathy: An Overview.
    Sagoo MK; Gnudi L
    Methods Mol Biol; 2020; 2067():3-7. PubMed ID: 31701441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.
    Low S; Lim SC; Wang J; Yeoh LY; Liu YL; Lim EK; Shao YL; Chui W; Fun S; Chua CL; Subramaniam T; Sum CF
    J Diabetes; 2018 Jul; 10(7):572-580. PubMed ID: 29154443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    J Nephrol; 2020 Feb; 33(1):9-35. PubMed ID: 31576500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapeutic considerations and treatment patterns of antihyperglycemic agents for diabetic nephropathy: a review of the literature.
    Jairoun AA; Ping CC; Ibrahim B
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):12058-12069. PubMed ID: 38164868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters.
    Al-Rubeaan K; Siddiqui K; Alghonaim M; Youssef AM; AlNaqeb D
    Ann Saudi Med; 2018; 38(1):46-56. PubMed ID: 29295969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.
    Zanella MT; Ribeiro AB
    Clin Ther; 2002 Jul; 24(7):1019-34. PubMed ID: 12182249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frailty, sarcopenia and diabetic kidney disease: where do we stand?
    Karakousis ND; Biliou S; Pyrgioti EE; Georgakopoulos PN; Liakopoulos V; Papanas N
    Int Urol Nephrol; 2023 May; 55(5):1173-1181. PubMed ID: 36352313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin therapy in renal disease.
    Iglesias P; Díez JJ
    Diabetes Obes Metab; 2008 Sep; 10(10):811-23. PubMed ID: 18248491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy.
    Conti G; Caccamo D; Siligato R; Gembillo G; Satta E; Pazzano D; Carucci N; Carella A; Campo GD; Salvo A; Santoro D
    Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31591338
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of Metformin Use in Diabetic Kidney Disease.
    Kawanami D; Takashi Y; Tanabe M
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Supersonic Shear Wave Imaging-Derived Renal Parenchyma Stiffness Between Diabetes Mellitus Patients With and Without Diabetic Kidney Disease.
    Shi LQ; Sun JW; Miao HH; Zhou XL
    Ultrasound Med Biol; 2020 Jul; 46(7):1630-1640. PubMed ID: 32404297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK.
    González-Pérez A; Saez M; Vizcaya D; Lind M; Garcia Rodriguez L
    BMJ Open Diabetes Res Care; 2021 Oct; 9(1):. PubMed ID: 34607828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.